Andrew Oxtoby
CIK 1765473 · See Remarks · last filed 2026-03-20
Andrew Oxtoby is a corporate insider who has filed 13 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for KLRS, was dated Mar 20, 2026. Across all open-market trades the lifetime net is +$44.3K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
13
$44.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | See Remarks | — | $4.33 | — | $0 | 2 | 2026-03-20 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | See Remarks | — | $9.81 | — | $0 | 1 | 2025-03-18 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Chief Commercial Officer | — | $40.39 | — | $0 | 2 | 2023-08-11 |
| COLL | Chief Commercial Officer | 0 | $34.64 | $0 | $44.3K | 8 | 2020-10-14 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-20 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2025-03-18 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-03-02 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-14 | COLL | Mixed | −26,595 | -$917.5K | EDGAR |
| 2020-09-16 | COLL | Tax (F) | −840 | -$28.8K | EDGAR |
| 2020-05-12 | COLL | Grant (A) | +2,420 | $0 | EDGAR |
| 2020-03-17 | COLL | Buy (P) | +3,000 | $44.3K | EDGAR |
| 2020-03-04 | COLL | Tax (F) | −1,235 | -$41.0K | EDGAR |